Hofseth BioCare ASA (OSL:HBC)
Norway · Delayed Price · Currency is NOK 1.345
+0.030 (2.28%)
Aug 4, 2026, 4:25 PM CET
Hofseth BioCare ASA Revenue
Hofseth BioCare ASA had revenue of 49.48M NOK in the quarter ending March 31, 2026, a decrease of -18.71%. This brings the company's revenue in the last twelve months to 244.95M, down -7.89% year-over-year. In the year 2025, Hofseth BioCare ASA had annual revenue of 256.34M, down -3.46%.
Revenue (ttm)
244.95M
Revenue Growth
-7.89%
P/S Ratio
2.87
Revenue / Employee
3.02M
Employees
84
Market Cap
702.41M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 256.34M | -9.20M | -3.46% |
| Dec 31, 2024 | 265.54M | 47.03M | 21.52% |
| Dec 31, 2023 | 218.51M | 98.06M | 81.42% |
| Dec 31, 2022 | 120.45M | 32.83M | 37.47% |
| Dec 31, 2021 | 87.62M | 18.36M | 26.52% |
| Dec 31, 2020 | 69.25M | 1.47M | 2.17% |
| Dec 31, 2019 | 67.78M | 7.04M | 11.59% |
| Dec 31, 2018 | 60.74M | -57.74M | -48.73% |
| Dec 31, 2017 | 118.48M | 98.27M | 486.40% |
| Dec 31, 2016 | 20.20M | -34.93M | -63.36% |
| Dec 31, 2015 | 55.14M | 35.37M | 178.91% |
| Dec 31, 2014 | 19.77M | -43.17M | -68.59% |
| Dec 31, 2013 | 62.94M | 36.92M | 141.92% |
| Dec 31, 2012 | 26.02M | 24.83M | 2,099.07% |
| Dec 31, 2011 | 1.18M | 1.01M | 591.81% |
| Dec 31, 2010 | 171.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Orkla ASA | 71.77B |
| Mowi ASA | 66.37B |
| SalMar ASA | 28.63B |
| P/F Bakkafrost | 10.85B |
| Arctic Fish Holding AS | 1.19B |
| Kaldvik AS | 1.07B |
| Dellia Group ASA | 731.14M |
| Lumi Education Group AS | 506.53M |
Hofseth BioCare ASA News
- 5 weeks ago - Hofseth BioCare ASA Quarterly report: Q1 2026 - Filings
- 2 months ago - Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026 - GlobeNewsWire
- 2 months ago - Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M - GlobeNewsWire
- 4 months ago - Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas - GlobeNewsWire
- 4 months ago - Hofseth BioCare ASA: HBC ANNUAL REPORT 2025 - GlobeNewsWire
- 6 months ago - Hofseth BioCare ASA: FOURTH QUARTER 2025 FINANCIAL REPORT - GlobeNewsWire
- 6 months ago - Hofseth BioCare ASA Annual report: Q4 2025 - Filings
- 6 months ago - Hofseth BioCare ASA Quarterly report: Q4 2025 - Filings